• Francisco Sanz, Eusebi Chiner, Laura Novella, Estrella Fernández-Fabrellas, Angela Cervera, María Carmen Aguar, José Noberto Sancho, Pedro Landete, and M Miralles.
• Chest. 2014 Mar 1;145(3 Suppl):144A.

Session TitleRespiratory Infections PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To assess the accuracy of different biomarkers (PaO2/FiO2 vs C-Reactive Protein, CRP) in predicting complications and mortality in bacteremic pneumococcal pneumonia (CAP-SP).MethodsWe analyzed the values of CRP and PaO2/FiO2 regarding pneumonia severity and the development of complications and mortality in a bacteremic pneumococcal pneumonia database. Means were compared with U Mann-Whitney test, and we performed analysis of variance (ANOVA) and ROC curves comparing both variables and outcomes.ResultsWe analyzed 117 patients of which 73.5% (86 cases) presented with severe pneumonia (PSI IV-V). Complications were developed in 69 cases (58.9%), and the most frequent were systemic and respiratory complications in 45 patients both (38.5%), followed by the presence of septic shock (40 cases, 34.2%) and ICU admission (28 patients, 23.9%). Overall 30-day mortality was 34.2% (40 patients). PaO2/FiO2 values worsened with PSI severity (p<0.01) but CRP levels showed no differences between risk classes (p=0.06). Patients with systemic and respiratory complications, septic shock and ICU admission had significantly lower levels of PaO2/FiO2, while no statistically significant differences in CRP values were found between patients who had a worse outcome compared to those who not. The ability to predict complications and 30-day mortality was higher for PaO2/FiO2 vs CRP (AUC PaO2/FiO2 0.72 vs. CRP 0.49; p<0.01) and AUC (PaO2/FiO2 0.67 vs. CRP 0.56; p=0.004), respectively.ConclusionsIn our series of bacteremic pneumococcal pneumonia, PaO2/FiO2 is a more accurate biomarker than CRP in predicting complications and mortality.Clinical ImplicationsThe assessment of a marker of target organ injury in CAP may offer a more useful prognostic information that the use of biomarkers of systemic infection.DisclosureThe following authors have nothing to disclose: Francisco Sanz, Estrella Fernández-Fabrellas, Ángela Cervera, Maria Luisa Briones, María Carmen Aguar, Eusebi Chiner, Laura Novella, José Noberto Sancho, Pedro Landete, M. Miralles, José BlanquerNo Product/Research Disclosure Information.

28 keywords...

hide…